Robeco Institutional Asset Management
ALXN

Robeco Institutional Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-61,756
Closed -$11.3M 981
2021
Q2
$11.3M Sell
61,756
-29,922
-33% -$5.5M 0.03% 463
2021
Q1
$14M Sell
91,678
-61,230
-40% -$9.36M 0.03% 412
2020
Q4
$23.9M Sell
152,908
-63,629
-29% -$9.94M 0.06% 302
2020
Q3
$24.8M Buy
216,537
+153,350
+243% +$17.5M 0.08% 261
2020
Q2
$7.09M Sell
63,187
-4,892
-7% -$549K 0.02% 473
2020
Q1
$6.11M Sell
68,079
-46,351
-41% -$4.16M 0.02% 508
2019
Q4
$12.4M Sell
114,430
-7,601
-6% -$822K 0.04% 445
2019
Q3
$12M Buy
122,031
+43,758
+56% +$4.29M 0.04% 416
2019
Q2
$10.3M Buy
78,273
+15,815
+25% +$2.07M 0.04% 462
2019
Q1
$8.44M Buy
62,458
+15,168
+32% +$2.05M 0.03% 494
2018
Q4
$4.6M Buy
47,290
+3,598
+8% +$350K 0.02% 551
2018
Q3
$6.07M Buy
43,692
+27,782
+175% +$3.86M 0.02% 529
2018
Q2
$1.98M Sell
15,910
-23
-0.1% -$2.86K 0.01% 666
2018
Q1
$1.77M Sell
15,933
-47
-0.3% -$5.23K 0.01% 682
2017
Q4
$1.91M Buy
15,980
+5,375
+51% +$642K 0.01% 621
2017
Q3
$1.49M Buy
10,605
+755
+8% +$106K 0.01% 609
2017
Q2
$1.2M Buy
9,850
+8,780
+821% +$1.07M 0.01% 641
2017
Q1
$131K Buy
1,070
+698
+188% +$85.5K ﹤0.01% 814
2016
Q4
$46K Sell
372
-9,537
-96% -$1.18M ﹤0.01% 783
2016
Q3
$1.21M Hold
9,909
0.01% 594
2016
Q2
$1.16M Hold
9,909
0.01% 590
2016
Q1
$1.38M Hold
9,909
0.01% 553
2015
Q4
$1.89M Buy
9,909
+1,574
+19% +$300K 0.02% 497
2015
Q3
$1.3M Buy
8,335
+1,399
+20% +$219K 0.01% 528
2015
Q2
$1.25M Sell
6,936
-1,258
-15% -$227K 0.01% 564
2015
Q1
$1.42M Sell
8,194
-10,600
-56% -$1.84M 0.01% 524
2014
Q4
$3.48M Buy
18,794
+2,729
+17% +$505K 0.02% 385
2014
Q3
$2.66M Buy
16,065
+1,712
+12% +$284K 0.02% 409
2014
Q2
$2.24M Buy
14,353
+6,387
+80% +$998K 0.02% 419
2014
Q1
$1.21M Buy
7,966
+6,798
+582% +$1.03M 0.01% 478
2013
Q4
$155K Hold
1,168
﹤0.01% 543
2013
Q3
$136K Hold
1,168
﹤0.01% 559
2013
Q2
$108K Buy
+1,168
New +$108K ﹤0.01% 549